Genetic Testing Helps Guide Treatment in Prostate Cancer
Danielle Bucco
Published: Wednesday, Mar 28, 2018
![Veda Giri, MD Veda Giri, MD](https://s3.amazonaws.com/onclive/_media/_upload_image/Veda-Giri.jpg)
Veda Giri, MD
There are several mutations that have been identified and associated with prostate cancer in various studies, such as BRCA1/2, mismatch repair deficient (dMMR) genes, and HOXB13. A discovered mutation could lead to additional treatment options or enrollment on clinical trials that were previously not available for a patient.1
No hay comentarios:
Publicar un comentario